Mining bacterial cell division for new antibacterial drugs

Monahan, LG; D'Elia, M; Harry, L

Mining bacterial cell division for new antibacterial drugs

Monahan, LG

D'Elia, M Harry, L

Permalink

Publisher:: Caister Academic Press
Publication Type:: Chapter
Citation:: Emerging Trends in Antibacterial Discovery: Answering the Call to Arms, 2011, 1, pp. 35 - 75
Issue Date:: 2011-01

Closed Access

	Filename	Description	Size
	2011000049OK.pdf		5.42 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Monahan, LG https://orcid.org/0000-0003-2933-9000	en_US
dc.contributor.author	D'Elia, M	en_US
dc.contributor.author	Harry, L https://orcid.org/0000-0003-0858-9473	en_US
dc.contributor.editor	Miller, AA	en_US
dc.contributor.editor	Miller, PF	en_US
dc.date.issued	2011-01	en_US
dc.identifier.citation	Emerging Trends in Antibacterial Discovery: Answering the Call to Arms, 2011, 1, pp. 35 - 75	en_US
dc.identifier.isbn	9781904455899	en_US
dc.identifier.uri	http://hdl.handle.net/10453/17774
dc.description.abstract	As bacterial antibiotic resistance continues to exhaust our supply of effective antibiotics, a global public health disaster appears likely. Poor financial investment in antibiotic research has exacerbated the situation. A call to arms raised by several prestigious scientific organisations a few years ago rallied the scientific community, and now the scope of antibacterial research has broadened considerably. Multi-disciplinary approaches have yielded a wealth of new data on areas ranging from the identification of novel antibacterial targets to the use of biological agents for antibacterial therapy.	en_US
dc.publisher	Caister Academic Press	en_US
dc.relation.ispartof	Emerging Trends in Antibacterial Discovery: Answering the Call to Arms	en_US
dc.title	Mining bacterial cell division for new antibacterial drugs	en_US
dc.type	Chapter
utslib.location	United Kingdom	en_US
utslib.for	110303 Clinical Microbiology	en_US
utslib.citation.edition	1	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Strength - ithree - Institute of Infection, Immunity and Innovation
utslib.copyright.status	closed_access
pubs.consider-herdc	true	en_US
pubs.edition	1	en_US
pubs.place-of-publication	United Kingdom	en_US
pubs.publication-status	Published	en_US

Abstract:

As bacterial antibiotic resistance continues to exhaust our supply of effective antibiotics, a global public health disaster appears likely. Poor financial investment in antibiotic research has exacerbated the situation. A call to arms raised by several prestigious scientific organisations a few years ago rallied the scientific community, and now the scope of antibacterial research has broadened considerably. Multi-disciplinary approaches have yielded a wealth of new data on areas ranging from the identification of novel antibacterial targets to the use of biological agents for antibacterial therapy.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/17774